Logo image of BW

BABCOCK & WILCOX ENTERPR (BW) Stock Fundamental Analysis

NYSE:BW - US05614L2097 - Common Stock

2.19 USD
-0.35 (-13.78%)
Last: 9/4/2025, 8:04:01 PM
2.3 USD
+0.11 (+5.02%)
Pre-Market: 9/5/2025, 8:00:04 AM
Fundamental Rating

2

Taking everything into account, BW scores 2 out of 10 in our fundamental rating. BW was compared to 92 industry peers in the Electrical Equipment industry. BW may be in some trouble as it scores bad on both profitability and health. BW is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BW has reported negative net income.
BW had a negative operating cash flow in the past year.
In the past 5 years BW reported 4 times negative net income.
BW had a negative operating cash flow in each of the past 5 years.
BW Yearly Net Income VS EBIT VS OCF VS FCFBW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

BW's Return On Assets of -23.28% is in line compared to the rest of the industry. BW outperforms 45.65% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.43%, BW belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BW is significantly below the industry average of 9.86%.
The 3 year average ROIC (3.67%) for BW is below the current ROIC(16.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -23.28%
ROE N/A
ROIC 16.43%
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
BW Yearly ROA, ROE, ROICBW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

BW has a better Operating Margin (6.02%) than 75.00% of its industry peers.
In the last couple of years the Operating Margin of BW has grown nicely.
Looking at the Gross Margin, with a value of 26.17%, BW is in line with its industry, outperforming 54.35% of the companies in the same industry.
BW's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) N/A
GM 26.17%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
BW Yearly Profit, Operating, Gross MarginsBW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

BW has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for BW has been increased compared to 1 year ago.
BW has more shares outstanding than it did 5 years ago.
BW has a worse debt/assets ratio than last year.
BW Yearly Shares OutstandingBW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BW Yearly Total Debt VS Total AssetsBW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -2.30, we must say that BW is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BW (-2.30) is worse than 66.30% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.3
ROIC/WACC2.27
WACC7.25%
BW Yearly LT Debt VS Equity VS FCFBW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

BW has a Current Ratio of 1.00. This is a bad value and indicates that BW is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 1.00, BW is not doing good in the industry: 70.65% of the companies in the same industry are doing better.
BW has a Quick Ratio of 1.00. This is a bad value and indicates that BW is not financially healthy enough and could expect problems in meeting its short term obligations.
BW has a Quick ratio (0.87) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.87
BW Yearly Current Assets VS Current LiabilitesBW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for BW have decreased strongly by -12.08% in the last year.
BW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.75%.
The Revenue has been decreasing by -3.54% on average over the past years.
EPS 1Y (TTM)-12.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215%
Revenue 1Y (TTM)-33.75%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-38.31%

3.2 Future

The Earnings Per Share is expected to grow by 26.39% on average over the next years. This is a very strong growth
Based on estimates for the next years, BW will show a decrease in Revenue. The Revenue will decrease by -3.90% on average per year.
EPS Next Y46.64%
EPS Next 2Y38.81%
EPS Next 3Y26.39%
EPS Next 5YN/A
Revenue Next Year-25.22%
Revenue Next 2Y-10.12%
Revenue Next 3Y-3.9%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BW Yearly Revenue VS EstimatesBW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BW Yearly EPS VS EstimatesBW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BW. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BW Price Earnings VS Forward Price EarningsBW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BW is valued cheaper than 84.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.53
BW Per share dataBW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as BW's earnings are expected to grow with 26.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.81%
EPS Next 3Y26.39%

More info and screens

0

5. Dividend

5.1 Amount

BW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BABCOCK & WILCOX ENTERPR

NYSE:BW (9/4/2025, 8:04:01 PM)

Premarket: 2.3 +0.11 (+5.02%)

2.19

-0.35 (-13.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners73.01%
Inst Owner Change-15.62%
Ins Owners3.7%
Ins Owner Change12.98%
Market Cap221.41M
Analysts80
Price Target2.72 (24.2%)
Short Float %2.26%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-9.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-279.85%
Min EPS beat(2)-579.61%
Max EPS beat(2)19.9%
EPS beat(4)2
Avg EPS beat(4)-1222.51%
Min EPS beat(4)-4779.86%
Max EPS beat(4)449.52%
EPS beat(8)2
Avg EPS beat(8)-1380.43%
EPS beat(12)2
Avg EPS beat(12)-966.37%
EPS beat(16)4
Avg EPS beat(16)-697.83%
Revenue beat(2)1
Avg Revenue beat(2)-5.71%
Min Revenue beat(2)-19.61%
Max Revenue beat(2)8.19%
Revenue beat(4)1
Avg Revenue beat(4)-7.8%
Min Revenue beat(4)-19.61%
Max Revenue beat(4)8.19%
Revenue beat(8)1
Avg Revenue beat(8)-9.02%
Revenue beat(12)5
Avg Revenue beat(12)-2.17%
Revenue beat(16)6
Avg Revenue beat(16)-2.84%
PT rev (1m)6.67%
PT rev (3m)14.29%
EPS NQ rev (1m)-54.54%
EPS NQ rev (3m)-439.95%
EPS NY rev (1m)-103.64%
EPS NY rev (3m)-199.99%
Revenue NQ rev (1m)-16.59%
Revenue NQ rev (3m)-25.93%
Revenue NY rev (1m)-12.31%
Revenue NY rev (3m)-15.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 14.53
EPS(TTM)-1.4
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS5.95
BVpS-3.06
TBVpS-3.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.28%
ROE N/A
ROCE 20.79%
ROIC 16.43%
ROICexc 18.77%
ROICexgc 35.25%
OM 6.02%
PM (TTM) N/A
GM 26.17%
FCFM N/A
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
ROICexc(3y)4.08%
ROICexc(5y)4.44%
ROICexgc(3y)6%
ROICexgc(5y)6.49%
ROCE(3y)4.64%
ROCE(5y)4.69%
ROICexcg growth 3Y18.44%
ROICexcg growth 5Y33.31%
ROICexc growth 3Y21.33%
ROICexc growth 5Y31.59%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.46
Cap/Depr 85.93%
Cap/Sales 1.71%
Interest Coverage 0.91
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.87
Altman-Z -2.3
F-Score3
WACC7.25%
ROIC/WACC2.27
Cap/Depr(3y)56.25%
Cap/Depr(5y)50.83%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215%
EPS Next Y46.64%
EPS Next 2Y38.81%
EPS Next 3Y26.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-33.75%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-38.31%
Revenue Next Year-25.22%
Revenue Next 2Y-10.12%
Revenue Next 3Y-3.9%
Revenue Next 5YN/A
EBIT growth 1Y68.04%
EBIT growth 3Y8.96%
EBIT growth 5Y36.41%
EBIT Next Year1.85%
EBIT Next 3Y13.99%
EBIT Next 5YN/A
FCF growth 1Y-2423.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1276.98%
OCF growth 3YN/A
OCF growth 5YN/A